ESR1 and breast carcinoma: Besides, Kv10.1 immuno-intensity increases with the grade of breast cancer and results higher in triple-negative samples which belong to the most aggressive phenotype (Liu et al., 2015; Li et al., 2017); however, the potential association between Kv10.1 and ERα expression in breast cancer needs further investigation.